6,7-Seco-ent-Kauranoids Derived from Oridonin as Potential Anticancer Agents

Area of Science:

• Natural Product Chemistry
• Medicinal Chemistry
• Pharmacology

Background:

• 6,7-seco-ent-kaurenes from the genus Isodon possess notable antitumor activities.
• Oridonin is a commercially available natural product that can be converted to 6,7-seco-ent-kaurenes.
• Previous work established a convenient synthesis of 6,7-seco-ent-kaurenes from oridonin.

Purpose of the Study:

• To design and synthesize novel spiro-lactone-type ent-kaurene derivatives.
• To explore seven-membered C-ring-expanded 6,7-seco-ent-kaurenes.
• To evaluate the anticancer potential of these novel compounds.

Main Methods:

• Synthesis of novel ent-kaurene derivatives from oridonin.
• Characterization of spiro-lactone and C-ring-expanded structures.
• In vitro antiproliferative assays against cancer cell lines.
• Mechanism of action studies including cell cycle analysis and apoptosis induction.
• In vivo efficacy and toxicity assessment in a mouse liver tumor model.

Main Results:

• Several novel spiro-lactone-type ent-kaurenes and C-ring-expanded 6,7-seco-ent-kaurenes were synthesized.
• Spiro-lactone derivatives exhibited significant inhibition of cancer cell proliferation, with IC50 values as low as 0.55 μM.
• Compound 7b induced cell cycle arrest and apoptosis in MCF-7 human breast cancer cells.
• Compound 7b demonstrated in vivo efficacy in inhibiting liver tumor growth with no observable toxicity.

Conclusions:

• The synthesized spiro-lactone-type ent-kaurenes represent a promising class of novel anticancer agents.
• Further preclinical investigations are warranted for these compounds.
• The study highlights the potential of modifying natural products like oridonin for drug discovery.